Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merge Healthcare, formerly known as Merge eMed, is a leading provider of medical imaging and clinical data software solutions. The company's portfolio includes enterprise imaging platforms, radiology information systems (RIS), and picture archiving and communication systems (PACS) used by hospitals and clinics worldwide. Merge also provides specialized software for clinical trials, helping researchers manage medical images and data across various therapeutic areas. In 2015, the company was acquired by IBM for approximately $1 billion to integrate its imaging data into the Watson Health platform. Following the sale of IBM Watson Health assets in 2022, Merge's technologies now operate under the Merative brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merge eMed.